Skip to content
Search

Latest Stories

Pharmacists pivotal in genotype testing for stroke and TIA patients, says NICE guidance

Pharmacists pivotal in genotype testing for stroke and TIA patients, says NICE guidance
"With pressures on GPs and secondary care, it makes sense to commission testing via community pharmacies", says community pharmacist and independent prescriber Atul Patel responding to the NICE guidance. 

The National Institute for Health and Care Excellence (NICE) has published a new diagnostic guidance to enhance CYP2C19 genotype testing to guide clopidogrel use for patients who have suffered an ischemic stroke or transient ischemic attack.

Published in July, the diagnostic guidance also emphasised the vital role of pharmacists and pharmacies in the implementation of CYP2C19 genotype testing used to guide prescribed antiplatelet medication.


According to the NICE guidance, pharmacists with their expertise in pharmacogenomics and patient medication management, will be integral in interpreting test results and recommending appropriate antiplatelet therapy.

It also highlighted the need for close collaboration with other healthcare professionals to ensure effective implementation across various care settings for stroke patients.

The diagnostics advisory committee, a standing advisory committee of NICE, agreed that it should be possible to gather samples for genotype testing at a location that is convenient for the person having the test and highlighted the role of pharmacies as accessible locations for CYP2C19 genotype testing.

The guidance suggests that utilising pharmacies for point-of-care testing can enhance the accessibility and convenience of the testing process, particularly in community settings.

To address this, the committee agreed that blood samples or cheek swabs for genotype testing could be collected at local pharmacies, GP surgeries, or even in patients’ homes, provided certain conditions are met.

This approach not only increases accessibility but also aligns with the broader NHS strategy of making healthcare services more community-focused.

The committee also raised concerns about potential delays in starting antiplatelet treatment while waiting for test results.

The model developed by the External Assessment Group (EAG) recommends initiating clopidogrel treatment immediately, with the option to switch to an alternative if the genotype testing later indicates a loss-of-function allele.

This ensures that treatment is not delayed, addressing a key concern raised by stakeholders.

There is also recognition of the higher prevalence of CYP2C19 loss-of-function alleles in certain populations, which could influence the choice of antiplatelet therapy.

A recent study, for example, reported that 57 per cent of a cohort from Bangladeshi and Pakistani backgrounds in the UK had at least one loss-of-function allele.

This data underlines the importance of personalised medicine, an area where pharmacists can play a significant role through shared decision-making with patients.

Personalised approach to prescribing

Expressing strong support for the integration of pharmacogentic testing into routine care, Atul Patel, an Independent Prescribing Pharmacist, told Pharmacy Business:

"I think there is a very strong case to introduce a personalised approach to prescribing through pharmacogenetic.

"Routine testing patients for common drug–gene interactions, which already happens in countries across the world, could reduce drug adverse reactions by a third and better guide appropriate drug use," he said.

"There are many potential drugs for pharmacogenomic testing but it makes sense to start with the most commonly prescribed medications such as benzodiazepines and clopidogrel (gene CYP2C19).

Patel also highlighted the relation between another gene type, CYP2D6, that is responsible for the metabolism and elimination of around a quarter of medicines.

He said that "variants can render people slow or fast metabolisers who would benefit from an adjustment of dose to suit the patients or prescribe an alternative that would be safer.

"With pressures on GP’s and secondary care it makes sense to commission testing via community pharmacies as many now who have trained phlebotomist on site making it easier for patients to access this service."

Reflecting on the recent ransomware cyber-attack against Synnovis, a pathology laboratory which processes blood tests on behalf of a number of NHS organisations, primarily in South East London- where Patel's pharmacy is located, he stated:

"The clinical impact of the attack had seen a significant reduction in the number of tests that could  be processed and reported back to clinical teams.

"To ensure continuity of care it would have made sense to commission blood testing via pharmacies that are already providing private blood test.

"A practical solution was in place but was not used to ensure continuity of care."

He believes that the integration of community pharmacy in the clinical pathway would ensure safe and tailored prescribing for patients in the future, for both GP's and  pharmacist, especially considering the introduction of the IP pathfinder program.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less